Back to all companies
Sign in
Back to all companies
Abalone Bio logo

Abalone Bio

Winter 2020Active

We create activating antibodies to treat diseases others can’t.

Save
Abalone Bio logo

Abalone Bio

Winter 2020Active

We create activating antibodies to treat diseases others can’t.

Save
Company details

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year.

High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs)

Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech.

Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value.

Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Location
San Francisco, CA, USA
Founded
Unknown
Category
Machine Learning
YC Directory Pagewww.abalonebio.com
Founders
  • RY
    Richard Yu
    Founder
    LinkedIn
  • GP
    Gustavo Pesce
    Founder
    LinkedIn

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year.

High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs)

Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech.

Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value.

Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Location
San Francisco, CA, USA
Founded
Unknown
Category
Machine Learning
YC Directory Pagewww.abalonebio.com
Founders
  • RY
    Richard Yu
    Founder
    LinkedIn
  • GP
    Gustavo Pesce
    Founder
    LinkedIn
Pro

Upgrade to Pro, then request the Abalone Bio teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate Abalone Bio. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first Abalone Bio teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong